BLOG
New FDA Clarification Allows Wholesale by 503B Facilities to 503A Pharmacies
New FDA Clarification Allows Wholesale by 503B Facilities to 503A Pharmacies | by: Sumeet Singh, Founder & Chairman | Article Posted: July 5, 2023 | New FDA Statement Overview The recent clarification from the U.S. Food and Drug Administration (FDA) regarding the...
Recent Articles
Manufacturers Don’t Forget: Virginia Drug Pricing Reports are Due April 1st
Manufacturers Don’t Forget: Virginia Drug Pricing Reports are Due April 1st Written-by: Deneen Fumich, RPh March 2021, Virginia passed the...
Do Drug Price Transparency Laws Need to Explicitly Define Reporting Entities?
Do Drug Price Transparency Laws Need to Explicitly Define Reporting Entities? Written-by: Deneen Fumich, RPh With the wave of 2021 passed Drug Price...
Importance of Current Good Manufacturing Practices (cGMP) Employee Training
Importance of Current Good Manufacturing Practices (cGMP) Written-by: Deneen Fumich, RPh Did you know that a common cause of failing FDA inspections...
NABP Drug Distributor Accreditation 2022 Recap
NABP Drug Distributor Accreditation Supply Chain Inspection Overview Written-by: Deneen Fumich, RPh Effective January 1, 2022, NABP made major...
FDA Proposed Rules Review, Part 1 of 4: An Introduction
FDA Proposed Rules Review, Part 1 of 4: An Introduction Written-by: Sumeet Singh, CEO This article will review the FDA’s proposed rule concerning...
FDA and NABP Temporarily Curtailing Onsite Inspections Due to COVID-19
FDA and NABP Temporarily Curtailing Onsite Inspections Due to COVID-19 In order to ensure the safety of its employees both FDA and the National...
